M. D. Anderson Home Page

New Clinical Trial

What is a clinical trial?
What is small cell lung cancer?
What is staging?
What is the standard treatment for small cell lung cancer?
What is high dose chemotherapy?
What are stem cells?
Am I a candidate for this trial?
How can I get more information about this clinical trial?
 

A New Clinical Trial For Small Cell Lung Cancer Is Now Enrolling

What is the standard treatment for small cell lung cancer?

In patients with small cell lung cancer, combination chemotherapy produces results that are superior to single-agent treatment. Standard treatment options include:

· Combination chemotherapy containing two or more drugs with or without radiation.

· Surgery is part of the treatment plan for a small number of patients.



What is high dose chemotherapy?

Certain cancers are not cured by conventional doses of chemotherapy. Some studies have shown that the response rate of certain cancer cells to chemotherapy is related to the dose of chemotherapy used to treat the cancer. One of the major limiting factors of the dose of chemotherapy used for the treatment of small cell lung cancer is bone marrow suppression (damage to the bone marrow which produces red blood cells, white blood cells to fight infection, and platelets to help control bleeding).

The cells in the bone marrow that can go on to develop into all the blood cells you need are called stem cells. With the help of stem cell reinfusion and hematopoietic growth factors (drugs used to stimulate the production of blood cells), it is possible to get a significant dose increase for certain chemotherapeutic drugs. A number of factors may have made high-dose chemotherapy less dangerous. One of these is the addition of peripheral stem cell harvest obtained after mobilization with chemotherapy followed by a hematopoietic growth factor, which seems to result in a faster recovery of neutrophils (the white blood cells that fight infection) and platelets compared to bone marrow reinfusion alone.